$36 Million, Highly Profitable Specialty Pharmacy Located in Texas
Texas Specialty Pharmacy Projects $36 Million Revenue
On NextCompany since August 28, 2026 (today)
TX area
Business overview
The specialty pharmacy operates in Texas. It focuses on rheumatology, dermatology, and GI diseases. Revenue grew from $22 million in 2017 to $31 million in 2018. Projected revenue reached $36 million. Adjusted EBITDA totals $1,500,000. Licensing covers 31 states. Full staff plans to remain. The asking price includes inventory costs.
Who is a good fit for this business
- Buyers targeting multi-state licensed pharmacies fit this Texas operation.
- Acquirers seeking $1.5 million EBITDA seek this specialty pharmacy.
- Investors interested in rheumatology and hepatitis treatments match this profile.
Details
- Reason for selling
- Pursue other business ventures
Frequently Asked Questions
Revenue grew from $22 million in 2017 to $31 million in 2018. Projections reached $36 million. Adjusted EBITDA stands at $1,500,000.
The pharmacy holds licenses in 31 states. Primary service focuses on Texas. Expansion potential exists through existing licenses.
Sellers pursue other ventures yet provide transition support. Full staff expects to stay. Inventory costs add to the $12 million asking price.
The pharmacy treats rheumatology, dermatology, GI diseases, hypercholesterolemia, viral hepatitis, and osteoporosis. It processes 1,000 scripts monthly.